Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07804589 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 4, 2026 (before its estimated October 4, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
To study the effect of a re-ascent after a one-week stay at sea level (after prior descent from 2850m) to high altitude (Quito Ecuador: 2850m) on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in healthy individuals, who live permanently \>2600m.
Trial Details
NCT Number NCT07804589
Lead Sponsor Silvia Ulrich Somaini
Conditions
(from sponsor)		 High Altitude, Healthy, Healthy Adult, High Altitude Effects, Pulmonary Resistance, Hemodynamic Changes, Echocardiography
Related terms Altitude Sickness, Hypoxia
Enrollment 14 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov